Valion Bio (VBIO) Common Equity (2021 - 2026)
Valion Bio (VBIO) recorded Common Equity of $4.25 million in Q2 2026, up 15.2% from $3.69 million a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Valion Bio reported Common Equity of $16.8 million, up 562.6% from FY2024.
- Annual Common Equity has a four-year compound annual growth rate of 6.1% (FY2021 to FY2025).
- Across earlier years, Common Equity came in at $2.54 million in FY2024 (-29.2%), $3.58 million in FY2023 (-1.4%), $3.63 million in FY2022 (-72.6%) and $13.27 million in FY2021.
- Quarterly Common Equity has ranged from -$5.79 million in Q3 2021 to $16.8 million in Q4 2025 over the past five years.
- On a year-over-year basis, Common Equity rose in four of the last seven quarters, with growth averaging 78.2%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 562.6% in Q4 2025, against a decline of 72.6% in Q4 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Valion Bio | 378,559.99 | -19.06 Mn | - | 4.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.25 Mn |
| Dec 31, 2025 | 16.80 Mn |
| Sep 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.69 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Jun 30, 2024 | 4.19 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 5.77 Mn |
| Jun 30, 2023 | 3.16 Mn |
| Mar 31, 2023 | 5.21 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Mar 31, 2022 | 11.09 Mn |
| Dec 31, 2021 | 13.27 Mn |
| Sep 30, 2021 | -5.79 Mn |
| Jun 30, 2021 | -3.60 Mn |
API Access
Valion Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();